1. Home
  2. INSP vs BLCO Comparison

INSP vs BLCO Comparison

Compare INSP & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inspire Medical Systems Inc.

INSP

Inspire Medical Systems Inc.

HOLD

Current Price

$130.44

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$16.99

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSP
BLCO
Founded
2007
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
6.0B
IPO Year
2018
2022

Fundamental Metrics

Financial Performance
Metric
INSP
BLCO
Price
$130.44
$16.99
Analyst Decision
Buy
Hold
Analyst Count
16
14
Target Price
$132.27
$17.31
AVG Volume (30 Days)
1.7M
399.7K
Earning Date
11-03-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
34.77
N/A
EPS
1.48
N/A
Revenue
$882,622,000.00
$4,976,000,000.00
Revenue This Year
$14.97
$8.08
Revenue Next Year
$11.81
$5.77
P/E Ratio
$88.30
N/A
Revenue Growth
16.81
6.23
52 Week Low
$70.77
$10.45
52 Week High
$216.01
$18.99

Technical Indicators

Market Signals
Indicator
INSP
BLCO
Relative Strength Index (RSI) 63.19 60.98
Support Level $132.39 $16.39
Resistance Level $147.03 $17.41
Average True Range (ATR) 8.60 0.46
MACD 0.20 0.06
Stochastic Oscillator 62.23 72.71

Price Performance

Historical Comparison
INSP
BLCO

About INSP Inspire Medical Systems Inc.

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: